AI in Drug Discovery Market Trends, Opportunities & Competitive Landscape
The AI in Drug Discovery Market is expected to experience substantial expansion as artificial intelligence becomes an increasingly important tool in pharmaceutical innovation. The market reached USD 2.81 billion in 2025 and is forecast to increase to USD 3.48 billion in 2026, before climbing to USD 23.95 billion by 2035. The projected CAGR is 23.90% from 2026 to 2035. Pharmaceutical companies are adopting AI to address rising research expenses, improve the selection of drug candidates, and make better use of complex biological information. Advances in machine learning, natural language processing, and molecular modeling are creating new possibilities across early-stage research and development.
By component, software solutions hold the leading position with an estimated 62% share, while service-based solutions are expanding as companies seek specialist support. Machine learning is a major technology segment, with applications in protein structure prediction and molecular optimization. Target identification and validation lead the application category, followed by hit and lead generation and preclinical development. Cloud-based systems account for approximately 64% of deployment, offering flexible computing and collaboration. North America remains the largest regional market, while Asia-Pacific is projected to grow fastest. Major participants include Insilico Medicine, Schrödinger, Recursion Pharmaceuticals, Exscientia, BenevolentAI, and Atomwise. Strategic partnerships, AI-designed biologics, and improved data integration are expected to influence the industry's next stage.
FAQs
-
What is the estimated market value in 2026?
The market is projected to reach USD 3.48 billion. -
What will drive demand for AI in drug discovery?
Rising R&D costs, growing biomedical data, and demand for more efficient drug development are key drivers. -
Which deployment model is most widely used?
Cloud-based deployment leads with approximately 64% of the market. -
Which region currently dominates the market?
North America holds the largest regional share, at approximately 42%. -
Who are the leading companies in this industry?
Major companies include Insilico Medicine, Schrödinger, Recursion Pharmaceuticals, Exscientia, BenevolentAI, and Atomwise.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness